GlassScriptPhysician profile
Leslie D Rosenberg
NPI 1235428905
$4,271.83
in general payments reported to CMS, 2019-2025
31 companies · $980 in 2025
The $980 reported for 2025 was more than what 80% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $329 · 2022: $933 · 2023: $1,153 · 2024: $877 · 2025: $980.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,010.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,009.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $719.23 | 2022-2025 | Breztri, Airsupra, Farxiga |
| Abbvie INC. | $589.50 | 2021-2025 | |
| Novo Nordisk INC | $382.69 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Teva Pharmaceuticals USA, INC. | $306.89 | 2021-2025 | Austedo Xr, Austedo Xr, Austedo |
| Amgen INC. | $283.75 | 2021-2025 | Repatha, Prolia, Evenity |
| Pfizer INC. | $263.82 | 2021-2025 | |
| Glaxosmithkline, LLC. | $242.11 | 2021-2025 | Trelegy Ellipta, Boostrix, Shingrix |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $209.64 | 2022-2024 | Caplyta |
| Exact Sciences Corporation | $162.48 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Janssen Biotech, INC. | $146.15 | 2024 | Tremfya |
| Janssen Scientific Affairs, LLC | $123.12 | 2022 | |
| Janssen Pharmaceuticals, INC | $115.60 | 2022-2025 | Spravato, Xarelto |
| Lilly USA, LLC | $113.65 | 2021-2025 | Mounjaro, Zepbound |
| Regeneron Healthcare Solutions, INC. | $85.26 | 2022 | |
| Abbott Laboratories | $75.87 | 2022-2025 | Freestyle Libre 3 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $60.39 | 2024 | |
| Dexcom, INC. | $47.29 | 2025 | Dexcom G6 Transmitter |
| Axsome Therapeutics, INC. | $42.87 | 2023-2024 | Auvelity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $40.87 | 2021-2022 | |
| Inspire Medical Systems, INC. | $39.26 | 2024-2025 | Inspire |
| Vanda Pharmaceuticals INC. | $32.28 | 2025 | Fanapt |
| Verona Pharma, INC. | $27.40 | 2025 | Ohtuvayre |
| Amarin Pharma, INC. | $27.32 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $21.20 | 2022 | |
| Novartis Pharmaceuticals Corporation | $20.34 | 2023 | |
| Radius Health, INC. | $18.65 | 2021 | |
| Althera Pharmaceuticals LLC | $18.63 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.87 | 2022 | |
| Azurity Pharmaceuticals, INC. | $15.29 | 2023 | Edarbi |
| Eisai INC. | $12.32 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $12.09 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leslie Rosenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.